Sun, Jennifer
Corradini, Stefan http://orcid.org/0000-0002-5990-806X
Azab, Feda
Shokeen, Monica
Muz, Barbara
Miari, Katerina E. http://orcid.org/0000-0003-3008-966X
Maksimos, Mina
Diedrich, Camila
Asare, Obed
Alhallak, Kinan
Park, Chaelee http://orcid.org/0000-0002-3909-0096
Lubben, Berit
Chen, Yixuan http://orcid.org/0000-0001-7496-9648
Adebayo, Ola
Bash, Hannah
Kelley, Sarah
Fiala, Mark http://orcid.org/0000-0002-0208-5023
Bender, Diane E. http://orcid.org/0000-0002-8311-4390
Zhou, Haibin
Wang, Shaomeng
Vij, Ravi
Williams, Mark T. S. http://orcid.org/0000-0003-1114-1418
Azab, Abdel Kareem http://orcid.org/0000-0002-6371-2780
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RR220088)
Paula C. and Rodger O. Riney Blood Cancer Research Initiative Fund
Article History
Received: 16 September 2022
Revised: 19 July 2024
Accepted: 19 August 2024
First Online: 30 August 2024
Competing interests
: Dr. Azab is the founder and owner of Cellatrix LLC that has an exclusive license for the 3DTEBM technology described in part of the experiments in this paper; however, Cellatrix has no contribution to this study. Other authors state no conflicts of interest.